Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04085510 · ClinicalTrials.gov registry record · NA
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania
A NA study of Breast Cancer and Neoplasms, sponsored by Wendie Berg.
- Active
- Registry status
- NA
- Development phase
- 1,647
- Enrollment target
- 3
- Study locations
NCT04085510: Active NA study of Breast Cancer and Neoplasms, sponsored by Wendie Berg.
NCT04085510 is a NA study of Breast Cancer and Neoplasms that is active but no longer recruiting, run by Wendie Berg. The registered enrollment target is 1,647 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (41% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04085510, a NA study of Breast Cancer and Neoplasms, is active but no longer recruiting, sponsored by Wendie Berg.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,647 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.
Primary Outcome
Number of participants with cancer detected with contrast-enhanced mammography compared to tomosynthesis. Number of patients recalled for additional testing by each imaging test who do not have cancer (false positives). Outcomes will be assessed for both prevalence and incidence screens.
Conditions Studied
Interventions
- DEVICE Contrast-enhanced mammogram
Study Locations (3)
Pennsylvania
- Magee Womancare Passavant Cranberry - Cranberry Township
- Magee Womancare Monroeville - Monroeville
- Magee Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,647 participants |
| Start Date | 2019-10-23 |
| Est. Completion | 2028-12-30 |
| Phase | NA |
What the registry record for NCT04085510 still lists
NCT04085510 is an interventional study that assigns participants to a tested intervention. Its 1,647 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (41% lower).
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Contrast-enhanced mammogram is the first listed.
NCT04085510 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04085510 about?
NCT04085510 is a clinical study titled "Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania". This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.
What is the current status of trial NCT04085510?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,647 participants. The study started on 2019-10-23. Estimated completion is 2028-12-30.
What conditions does trial NCT04085510 study?
This clinical trial studies the following conditions: Breast Cancer, Neoplasms, Breast Neoplasms, Breast Cancer Female.
What interventions are being tested in trial NCT04085510?
The interventions under investigation include: Contrast-enhanced mammogram (DEVICE).
Who is sponsoring clinical trial NCT04085510?
This trial is sponsored by Wendie Berg, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04085510 being conducted?
This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04085510's enrollment target sits among peer trials
1,647 80th of 1224 higher than 1,145 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- NCT07046260 · 1,650 participants
Prospective Study to Assess a Diagnostic Aid for Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI